Sep 2026· Medical Studies· 0 citations· 45 references
TL;DR
A reduction in epithelial cell height was observed, along with increased apoptosis of cells in the apical surface of the jejunal villi, as well as changes in the immunoexpression levels of intercellular tight and adhesion junction proteins.
Abstract
Long-term immunosuppressive therapy in organ recipients reduces the frequency and severity of graft rejection. However, it can also produce various side effects. Clinical evidence indicates that immunosuppressive drugs can have deleterious effects on the structure and function of the gastrointestinal epithelium, making it more susceptible to infectin, inflammation, and damage. It has also been documented that calcineurin inhibitors such as cyclosporine A (CsA) and tacrolimus (TAC) can have several effects on the morphology of various tissues.
The aim of the study was to evaluate the effects of chronic treatment of adult male rats with a three-drug regimen based on calcineurin inhibitors (CNIs) – cyclosporine A and tacrolimus in combination with rapamycin and glucocorticoid – on the morphology and function of the mucosal epithelium of the jejunum.
Paraffin-embedded jejunum samples from 14-week-old male rats were analysed. The rats received immunosuppressive regimens based on calcineurin inhibitors with rapamycin and prednisone for 6 months. Histological (H-E) and immunohistochemical staining (annexin V, occludin, E-cadherin, vinculin) were performed. Digital image and histomorphometric analyses were conducted. The results underwent statistical evaluation using appropriate parametric and non-parametric tests.
After 6 months of treatment with calcineurin inhibitors, a reduction in epithelial cell height was observed, along with increased apoptosis of cells in the apical surface of the jejunal villi, as well as changes in the immunoexpression levels of intercellular tight and adhesion junction proteins. This effect was more pronounced in the TRG group of rats.
Background/Objectives: Long-term immunosuppressive therapy administered to solid organ transplant recipients may induce adverse effects in various tissues, including the gastrointestinal tract. The aim of the present study was to evaluate the influence of prolonged treatment with calcineurin inhibitor (CNI)-based tripl...
K. Szumilas, A. Wilk, P. Szumilas et al.· Biomedicines· 0 citations
Current evidence regarding the role of TGFB1 gene polymorphisms in the development of post-transplant complications and their potential impact on calcineurin inhibitor dosing are analyzed to optimize immunosuppressive therapy in solid organ transplant recipients.
R. Kurabekova, M. S. Vlasov, O. E. Gichkun Ersin et al.· Russian Journal of Transplan...· 0 citations
This comprehensive review provides a detailed organ-resolved and translational synthesis of the effects of calcineurin inhibitors, such as cyclosporine A (CsA) and tacrolimus (FK506), on male reproductive function following kidney transplantation. This review summarises experimental and clinical evidence relating to th...
Marta Grabowska, Małgorzata Piasecka· International Journal of Mol...· 0 citations
Since the 1980s, calcineurin inhibitors (CNI) have been widely used as immunosuppressive agents in solid organ transplantation and in the treatment of immune-mediated glomerular diseases, including complicated nephrotic syndrome. However, CNI-induced nephrotoxicity (CNIT) remains one of the most frequent adverse effect...
A. M. Khokhlova, E. Stolyarevich, L. Prikhodina· Nephrology and Dialysis· 0 citations
Calcineurin inhibitors (CNIs), including tacrolimus and cyclosporin A, are potent immunosuppressive drugs that exert their effects by inhibiting protein phosphatase 3, also known as calcineurin. CNIs are widely used clinically, particularly for preventing organ rejection following transplantation. However, their use is...
W. V. van Megen, J. Loffing· American Journal of Physiolo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.